NCT03302312

Brief Summary

This qualitative study will use focus groups, small group interviews, and individual interviews (both in person and over the phone) to compile a range of perspectives on service members' decision-making processes and information needs related to Stellate Ganglion Block (SGB). Participants will include service members, spouses, and providers.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 5, 2017

Completed
29 days until next milestone

Study Start

First participant enrolled

November 3, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2018

Completed
Last Updated

July 30, 2018

Status Verified

July 1, 2018

Enrollment Period

4 months

First QC Date

September 28, 2017

Last Update Submit

July 27, 2018

Conditions

Keywords

Posttraumatic Stress DisorderGeneralized Anxiety DisorderDepressionDistressAlcohol UsePain

Outcome Measures

Primary Outcomes (2)

  • Participants' perceptions of SGB in relation to other options for treatment of PTSD, from the perspectives of service members or service member/spouse couples.

    Discussion topic areas: * Context for mental health and treatment * Advantages and drawbacks of treatment options * Information and decision-making * Experience and expectations

    Within three month of receiving one SGB study procedure for PTSD symptoms

  • Participants' perceptions of SGB in relation to other options for treatment of PTSD, from the perspectives of providers

    Discussion topic areas: * Context for mental health and treatment * Advantages and drawbacks of treatment options * Information and decision-making * Experience and expectations

    Through study completion, approximately six months

Study Arms (2)

Participants

Service members who received at least one SGB study procedure as part of the clinical effectiveness trial during the three months prior to qualitative data collection or service members who received at least one SGB for PTSD symptoms at a study site in the three months prior to qualitative data collection.

Providers

Behavioral Health or other (e.g., Family Medicine) clinicians who have referred or could potentially have referred service members for SGB for PTSD symptoms, as well as physicians who provide SGBs.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* participants in effectiveness clinical trial and their spouses * service members who have received SGB for PTSD symptoms at the participating study sites outside of the clinical trial and their spouse * providers who have referred or could potentially have referred patients for SGB for PTSD symptoms at the study sites * clinicians who provide SGB for PTSD

You may qualify if:

  • Service members must have received at least one SGB and/or study procedure for PTSD symptoms during the past three months at a participating study site (as a participant in the clinical effectiveness trial or outside of the study).
  • Clinical trial participants must have indicated willingness to participate in the qualitative study when asked by the Research Coordinator (RC) at baseline data collection.
  • Non-clinical trial participants must be active-duty status.
  • A service member/spouse dyad will consist of a service member meeting an above criterion and his/her spouse.
  • Providers will be Behavioral Health or other (e.g., Family Medicine) clinicians who have referred or could potentially have referred service members to the study, and physicians who administer SGBs.

You may not qualify if:

  • Service members will be excluded from the qualitative study if participation would cause them undue distress, in the opinion of the RC or treating clinician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Tripler Army Medical Center (TAMC)

Honolulu, Hawaii, 96859, United States

Location

Womack Army Medical Center (WAMC)

Fort Bragg, North Carolina, 28310, United States

Location

Landstuhl Regional Medical Center (LRMC)

Landstuhl, 66849, Germany

Location

Related Publications (1)

  • Krueger, R.A., & M.A. Casey, M. A. (2000). Focus groups. A practical guide for applied research. Thousand Oaks, CA: Sage.

    BACKGROUND

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticGeneralized Anxiety DisorderDepressionAlcohol DrinkingPain

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersAnxiety DisordersBehavioral SymptomsBehaviorDrinking BehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bradford B Walters, MD, PhD, MBA

    RTI International

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2017

First Posted

October 5, 2017

Study Start

November 3, 2017

Primary Completion

March 2, 2018

Study Completion

March 2, 2018

Last Updated

July 30, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations